LM1503

21:0-22:6 PI

Avanti Research^™ - A Croda Brand

• Synonym(e): 1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt)
• Empirische Formel (Hill-System): C₅₂H₉₂NO₁₃P
• CAS-Nummer: 1246304-60-8
• Molekulargewicht: 970.26
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: methanol solution
• Verpackung: pkg of 1 × 1 mL (LM1503-1EA)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Konzentration: ~10 μg/mL (Refer to C of A for lot specific concentration. )
• Anwendung(en): lipidomics; metabolomics
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CCCCCCCCCCCCCCCCCCCC)=O.[NH4+]

Beschreibung

Anwendung

21:0-22:6 PI or 1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1′-myo-inositol) has been used as an internal standard for phospholipid quantification using electrospray ionization tandem mass spectrometry (ESI-MS/MS) and for lipid quantification using liquid chromatography mass spectrometry (LC-MS).

Verpackung

2 mL Amber Glass Sealed Ampule (LM1503-1EA)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes,Central nervous system
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup